Annals of internal medicine

• Latest
• Best
• Search…

• Ann. Intern. Med. · Jun 2021

  Comment

  In HFrEF, adding empagliflozin to medical therapy reduced a composite outcome, regardless of CKD status.

  Zannad F, Ferreira JP, Pocock SJ, et al. Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function: insights from EMPEROR-Reduced. Circulation. 2021;143:310-21. 33095032.

  keep going… or not…

• Ann. Intern. Med. · Jun 2021

  Summary for Patients: Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV.

  no abstract available

  explore further… or not…

• Ann. Intern. Med. · Jun 2021

  Editorial

  Another Two Mass Shootings: Déjà Vu All Over Again.

  no abstract available

  expand abstract… mark as read…

• Ann. Intern. Med. · Jun 2021

  Correction: Revisiting the National Institutes of Health Fair Pricing Condition.

  no abstract available

  read more… mark as read…

• Ann. Intern. Med. · Jun 2021

  Comment Letter

  Obesity and Mortality Among Patients Diagnosed With COVID-19.

  no abstract available

  read on… or not…